Novel Antibacterial Vaccines

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: closed (30 October 2021) | Viewed by 519

Special Issue Editors


E-Mail Website
Chief Guest Editor
Wellcome-Wolfson Institute of Experimental Medicine, Belfast BT9 7BL, UK
Interests: immunogenicity; infectious diseases; antibacterial vaccines;vaccination ; epidemic disease; public health

E-Mail Website
Guest Editor
Department of Biology, Maynooth University, Maynooth, Co. Kildare, Ireland
Interests: vaccines; vaccination; innate immunity; delivery technologies; intradermal; host-pathogen interactions
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Co-Guest Editor
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Rocky Mountain Laboratories, Hamilton, MT, USA
Interests: vaccinology; immunology; bacterial vaccines; bacterial pathogen; hypersensitivity

Special Issue Information

Dear Colleagues,

Vaccines are the most effective medical intervention for protecting against infectious disease and prevent an estimated 2 million deaths per year. While impressive progress has been made in vaccine development, vaccines are still only available for some, but unfortunately not all bacterial pathogens. Thus, bacterial infections still represent a major global health problem. Added to this threat is the increasingly frequent acquisition of multidrug-resistant strains for which limited or no treatment options are available. 

A comprehensive understanding of the immunological mechanisms involved in protection against pathogens is warranted, to facilitate rational design of vaccines directed at more complex pathogens. Immense progress has been made in this field in recent years, and increased knowledge of the signals that determine the immune response against a given pathogen means that immunology can now offer payback to vaccinology, by helping to guide the development of novel vaccines against bacterial infections. Moreover, the influence of vaccine delivery routes on efficacy and novel delivery approaches to enhance the mode of action has only in recent years been appreciated.

 In this context, we encourage and appreciate the presentation of this Special Issue on novel antibacterial vaccines and delivery approaches. These articles will encapsulate the current dynamism of this field, focusing on the contribution of immunology to the rational design and development of novel antibacterial vaccines. Contributions addressing the impact of vaccine delivery routes and novel delivery approaches will also be appreciated. 

We encourage your submission, with a short turnaround time for publication. 

Dr. Rebecca Ingram
Dr. Aoife Rodgers
Dr. Carrie Mae Long
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pathogens
  • antibacterial vaccines
  • pathogens and host determinants
  • immune response
  • AMR

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop